Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III double-blind randomized placebo-controlled study of RO4607381 in recent acute coronary syndrome
2007-005103-18Phase 3Completed
- Sponsor
- Roche
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dalcetrapib in coronary arteriosclerosis, acute coronary syndrome (ACS), sponsored by Roche. Started Feb 2008; status: completed.
02
Drugs
dalcetrapib
03
Conditions
coronary arteriosclerosisacute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2007-005103-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005103-18.